solubl interleukin receptor lung cancer indirect marker tumor activ level solubl interleukin receptor vivo measur immunolog respons human tumor total serum assay patient lung cancer diagnosi treatment patient pulmonari benign diseas voluntari healthi subject patient lung cancer median valu u/ml superior control u/ml patient noninflammatori benign diseas u/ml infecti pulmonari disord tuberculosi pneumonia valu substanc median u/ml diagnosi lung cancer stage diseas cell type contrari posttreat level receptor statu RO subgroup nonsurg patient RO patient abnorm level signific reduct surviv patient normal valu measur use patient treatment bronchogen carcinoma prognost set new class biolog marker inform complementari classic tumor-deriv marker 